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osting by EAbstract Purpose: To compare the surgical outcomes of phacoemulsiﬁcation–subscleral trabecu-
lectomy versus phacoemulsiﬁcation–deep sclerectomy with intraoperative mitomycin C in open-
angle glaucoma.
Methods: The study was conducted on 40 chronic primary open-angle glaucomatous eyes with
senile cataract. They were divided into two groups: group I (n= 20): eyes undergoing phacoemul-
siﬁcation with subscleral trabeculectomy, and group II (n= 20): eyes undergoing phacoemulsiﬁca-
tion with deep sclerectomy. Intraoperative mitomycin C (0.4 mg/ml for 3 min) was applied in both
groups. Postoperative intraocular pressure (IOP), complications, glaucoma medications, visual out-
comes, and the bleb appearance were assessed for 12 months.
Results: The mean postoperative IOP was signiﬁcantly lower (P< 0.05) in both groups in all
time intervals in comparison to their preoperative values. The mean postoperative IOP was
14.1 ± 5.4 mmHg in group I, and 14.8 ± 3.1 mmHg in group II. No major complications were
encountered in either procedure, but complications such as shallow anterior chamber, hypotony,
and delayed bleb leaks were common in group I, whereas intraoperative perforation of Descemet’s
membrane occurred in group II. No signiﬁcant difference in visual acuity improvement, visual ﬁeld
changes, and surgical success outcome were found between both groups..com (A.A. Ghanem).
ity. All rights reserved. Peer-
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190 T.H. Mokbel et al.Conclusion: There was no signiﬁcant difference in IOP reduction, surgical complications and visual
outcomes between subscleral trabeculectomy, or deep sclerectomy with intraoperative mitomycin C
in combination with phacoemulsiﬁcation and intraocular lens implantations in patients with pri-
mary open-angle glaucoma.
ª 2009 King Saud University. All rights reserved.1. Introduction
Ophthalmologists have many options in treating patients with
both cataract and glaucoma. Combined cataract and glau-
coma surgery decision depends on several individual patients
factors including the degree of visual improvement, target
IOP, stage of glaucoma, compliance, age and life expectancy
(Vass and Menapace, 2004).
Recent advances in cataract incision techniques and in glau-
coma medications have changed the indications for surgery by
minimizing the severity of complications. In early 1980s, extra-
capsular cataract extraction with trabeculectomy were reported
to be effective but larger wound size was associated with more
inﬂammation and hyphema (McCartney et al., 1988). In 1990s,
phacoemulsiﬁcation and the use of small incision foldable lenses
increased the success of combined phacoemulsiﬁcation trabecu-
lectomy surgery (Friedman et al., 2002). Augmentation of the
procedure with mitomycin C (MMC) has been shown to be ben-
eﬁcial when risk factors for failure are present (Shin et al., 1998).
Trabeculectomy has been a standard procedure for medi-
cally uncontrollable glaucoma. Friedman et al. (2002) reported
the superior hypotensive effect of combined trabeculectomy
and phacoemulsiﬁcation in comparison with cataract surgery
alone. However, several studies reported that phacotrabeculec-
tomy provided less intraocular pressure reduction, and smaller
success rates compared with trabeculectomy alone (Lochhead
et al., 2003).
More recently, non-penetrating procedures as deep sclerec-
tomy with or without an intrascleral implant, as well as
viscocanalostomy have been developed as alternative to trabec-
ulectomy. Non-penetrating anti-glaucoma procedures com-
bined with cataract surgery have also been advocated as useful
means of treating eyes with open-angle glaucoma and visually
signiﬁcant cataract (D’Eliseo et al., 2003; Shaarawy et al.,
2003). The success rates of deep sclerectomy can be improved
and IOPs in the low teens achieved by using intraoperative
MMC application (Anand and Atherley, 2005).
The aim of this study was to compare the outcomes of
phaco-subscleral trabeculectomy and phaco-deep sclerectomy
with mitomycin C in eyes with primary open-angle glaucoma.
2. Materials and methods
This is a prospective, comparative randomized study.
2.1. Patients
This study included 40 eyes of 30 patients with visually signif-
icant cataract and chronic primary open-angle glaucoma with
an IOP of 22 mmHg or more despite medical therapy. A diag-
nosis of glaucoma was based on the appearance of optic nerve
head cupping, gonioscopy results, and visual ﬁeld alteration.Eyes included in the study were divided into two groups:
Group I: included 20 eyes of 15 patients undergoing phaco-
emulsiﬁcation with subscleral trabeculectomy. Their age
ranged from 45 to 62 years.
Group II: included 20 eyes of 15 patients undergoing phac-
oemulsiﬁcation with deep sclerectomy. Their age ranged
from 45 to 60 years.
In either group I or II, intraoperative mitomycin C (MMC)
(0.4 mg/ml (0.04%) for 3 min) was applied.
2.2. Preoperative assessment
All patients were subjected to full ophthalmic examination
including; visual acuity assessment, slit-lamp biomicroscopy
for (assessment of corneal clarity, anterior chamber depth, not-
ing of lens morphology and grading the nuclear hardness),
Goldmann applanation tonometer, Humphery 24-2 visual ﬁeld
analysis, fundus examination, B-scan ultrasonography, kera-
tometry, biometry and refraction (if possible).
In addition, clinical data as age, gender, history of ocular
inﬂammation, history of any surgical intervention, and anti-
glaucoma medical regimen were collected.
2.3. Exclusion criteria
Exclusion criteria included eyes with soft nuclei or very hard
nuclei, shallow anterior chamber, signiﬁcant corneal opacity,
previous intraocular surgery, congenital or juvenile glaucoma,
angle-closure glaucoma, high risk glaucoma patients, and ocu-
lar diseases (uveitis and retinopathy).
2.4. Surgical procedures
All surgeries were performed by a single surgeon (A.I.M.).
Phacoemulsiﬁcation and intraocular lens implantation was
performed through a temporal corneal incision separate from
the subscleral trabeculectomy site or deep sclerectomy site.
A lid speculum was applied in the eye and a superior rectus
traction suture used to inferoduct and manipulate the globe
during the procedure.
2.5. Phacoemulsiﬁcation
A fornix-based conjunctival ﬂap was raised at the 12 o’clock po-
sition. A 19-gauge keratome was used to create 2 clear corneal
incisions at the 10 o’clock and 2 o’clock positions. A curvilinear
capsulorhexis was created with a capsulorhexis forceps (Bausch
&Lomb surgical) through the 10 o’clock corneal wound under a
healon (sodium hyaluronate 1%). Hydrodissection and hyd-
rodelineation were performed. The sleeveless phaco needle
Figure 1 (a) Excision of trabecular block and (b) peripheral
iridectomy.
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wound, while the Aggrawal irrigation chopper (20 gauge or
0.9 mm outer diameter, 0.7 mm bore, 65 cm3/min ﬂow rate) en-
tered the anterior chamber through the 2 o’clock cornealwound.
A standard bimanual phacoemulsiﬁcation technique was
performed using the divide and conquer technique. A deep
groove was made within the conﬁne of capsulorhexis. Then,
the groove was gradually deepened until it was seen that the
epinucleus plate has been penetrated. The nucleus and epinu-
cleus were then fractured using the phaco tip and a nucleus
manipulating hook. A second groove was performed perpen-
dicular to the ﬁrst and each half was fractured into two quad-
rants. Phaco machine settings during stage 1 were power 45–
50%, vacuum 40–80 mmHg, and ﬂow rate 24 ml/min. The bot-
tle height was routinely set 100 cm above eye level to start and
then adjusted according to anterior chamber depth. Phaco ma-
chine settings during stage 2 were power 45–50%, hyperpulse
mode at 50 Hz, vacuum 280 mmHg, and ﬂow rate 24 ml/
min. However, these parameters have been changed according
to the hardness of the nucleus. Bimanual irrigation/aspiration
(I/A) was completed through the 2 corneal wounds, followed
by reformation of anterior chamber and capsular bag with a
healon. A 3-piece hydrophobic acrylic intraocular lens was im-
planted in the capsular bag through the 3.0 mm incision. Re-
moval of any residual viscoelastic from the anterior chamber.
2.6. Subscleral trabeculectomy
The surgery was performed as follow: after making a fornix-
based conjunctival ﬂap. A limbus-based rectangular scleral
ﬂap 3 · 4 mm about half scleral thickness was created to clear
cornea. Careful haemostasis of the exposed sclera using wet
ﬁeld cautery was performed. Mitomycin C 0.4 mg/ml
(0.04%) soaked sponges were placed underneath the scleral
ﬂap for 3 min, then the area irrigated with 500 ml saline. Tra-
beculectomy was done beneath the scleral ﬂap 1 · 3 mm and
peripheral iridectomy was performed (Fig. 1a and b). The
lamellar scleral ﬂap was closed with 10-0 nylon sutures ad-
justed to allow minimal leakage during reformation of anterior
chamber. Finally, Tenon’s layer and the conjunctiva were
tightly closed separately with 10-0 nylon sutures.
2.7. Deep sclerectomy
The surgery was performed as follow: after making a fornix-
based conjunctival ﬂap, a 5 · 5 superﬁcial scleral ﬂap was dis-
sected. Careful haemostasis of the exposed sclera using wet
ﬁeld cautery was performed. Mitomycin C 0.4 mg/ml
(0.04%) soaked sponges were placed underneath the scleral
ﬂap for 3 min, then the area irrigated with 500 ml saline.
The superﬁcial scleral ﬂap has to be continued 1–1.5 mm
anteriorly into clear cornea. A second deep scleral ﬂap
4 · 4 mm and leaving about 10% of the sclera over the choroid
and ciliary body was dissected. A horizontal dissection was
performed starting posteriorly and moving anteriorly using a
crescent blade. Schlemm’s canal was automatically unroofed
near the limbus (Fig. 2a). To facilitate the identiﬁcation of
the Schlemm’s canal, the assistant should keep the dissection
area dry. Also, the tissue can be pushed laterally with the cut-
ting blade for a clearer vision of the Schlemm’s canal. The dis-
section was continued anteriorly using a blunt spatula orsponge to ﬁnd the natural cleavage plane between Descemet’s
membrane and corneal stroma. When Descemet’s membrane
has been exposed for 1 mm, the second deep scleral ﬂap was
excised (Fig. 2b). At this stage, aqueous was seen percolating
through the anterior trabeculum and Descemet’s membrane.
The superﬁcial scleral ﬂap was sutured with 10-0 nylon sutures
(usually 2 sutures, one at each corner).
Following surgery, all eyes received topical antibiotic and
corticosteroid three times daily, then they tapered and discon-
tinued after 4–6 weeks. The patients were followed up for
12 months. Patients were examined 1 day postoperative, then
every week in the ﬁrst month, then monthly.
2.8. Follow-up of patients
The outcome of the surgical procedures were evaluated accord-
ing to:
 Intraocular pressure (IOP) without medication. Three mea-
surements with Goldmann applanation tonometer were
recorded in each eye, the mean of which was used in the
calculation.
 Visual ﬁeld testing with a Humphrey automated visual ﬁeld
analyzer (Humphrey Zeiss, Dublin, CA) program 24-2 cen-
tral threshold was carried out before surgery and 6,
12 months after surgery.
 Best-corrected visual acuity was measured using snellen line
chart, and the logarithm of the minimum angle of resolution
Figure 2 (a) Derooﬁng of canal of Schlemm and (b) excision of
the deep scleral ﬂap.
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ysis. An increase or decrease in visual acuity was deﬁned as a
change of more than 0.2 in logarithm of the minimum angle
of resolution visual acuity.
 Biomicroscopic classiﬁcation of the ﬁltering bleb (Picht and
Grehn, 1998) into: type 1 bleb, presence of microcysts, dif-
fuse borders and no or little vascularization (favourable
bleb). Type III bleb, presence of corkscrew vessels, promi-
nent vascularization, dense scar tissue and demarcation of
bleb borders (unfavourable bleb). Type II bleb, intermedi-
ate bleb (less favourable bleb).Table 1 Preoperative demographic and clinical data of the studied
Parameters Group
Phaco-subscleral trabec
Number of eyes 20
Mean age (years) 54.5 ± 2.5
Gender (M:F) 8:12
Mean IOP (mmHg) 23.5 ± 2.1
Mean cup:disc ratio 0.65 ± 0.21
Mean deviator (dB) 17.50 ± 5.41
Log MAR best corrected V.A 0.795 ± 0.81
No. of anti-glaucoma medication 2.1 ± 0.8
M:F, Male:female; IOP, intraocular pressure; V.A, visual acuity; Log M
a Results of the paired t-test and v2-test. Presence of complications such as perforation Descemet’s
membrane, shallow anterior chamber, hypotony, IOP spike,
hyphema, posterior synechiae, rupture of posterior lens
capsule, and vitreous loss were recorded.
 Need for further treatment (needling, 5-ﬂuorouracil injec-
tion (0.2 ml/5 mg), and selective argon Laser suturelysis in
the subscleral trabeculectomy group, and Nd:YAG Laser
goniopuncture in the deep sclerectomy group). Goniopunc-
ture was done using YAG Laser in the free running Q-
switched mode, energy ranging from 4 to 8 mj, 4–15 shots
were applied. The aiming beam was focused on the semi-
transparent trabeculodescemetic membrane, with a gonios-
copy contact lens.
Success of the procedure was deﬁned as a complete success
with an IOP between 6 and 20 mmHg and an IOP reduction
of 30% or more without glaucoma medication or additional
surgery, compared with the preoperative level with medical
therapy. A qualiﬁed success was deﬁned as an IOP of between
6 and 20 mmHg with glaucoma medication or an IOP reduc-
tion of less than 30% compared with the preoperative level
with medical therapy. A failure was deﬁned as an eye requiring
further glaucoma surgery.
2.9. Statistical analysis
Was done using SPSS program version 10. Student’s t-test was
for comparing means of quantitative data. To evaluate the dif-
ference in IOPs between follow-up intervals, the paired t-test
was used. All t-test were tailed. Categoric variables were eval-
uated with the v2-test, or the Spearman rank correlation as
appropriate. A level of P < 0.05 was considered statistically
signiﬁcant. Success was evaluated on the basis of Kaplan–Me-
ier cumulative probability (long-rank test).
3. Results
The study included 40 eyes of total 30 patients had combined
cataract and glaucoma surgery, 20 eyes had phacoemulsiﬁca-
tion with subscleral trabeculectomy (group I), and 20 eyes
had phacoemulsiﬁcation with deep sclerectomy (group II).
Table 1 list preoperative demographic and clinical character-
istics of patients in the studied groups. There was no statistically
signiﬁcant difference in age, gender, mean IOP, mean cup:disc
ratio, mean deviation, logarithm of minimum angle ofpatients.
Pa
ulectomy Phaco-deep sclerectomy
20
56.2 ± 3.4 0.85
7:11 0.75
24.1 ± 1.5 0.68
0.66 ± 0.25 0.75
18.83 ± 5.61 0.52
0.641 ± 0.28 0.75
2.2 ± 0.6 0.46
AR, logarithm of minimum angle of resolution; No., number.
Table 2 Postoperative IOP (mmHg) results of the studied
patients.
Parameters Group Pa
Phaco-subscleral
trabeculectomy
Phaco-deep
sclerectomy
Baseline 23.5 ± 2.1 24.1 ± 1.5 0.68
One week postop. 11.1 ± 2.1 11.3 ± 3.0 0.12
One month postop. 12.1 ± 2.2 12.9 ± 2.9 0.18
Three months postop. 12.4 ± 2.6 13.1 ± 3.1 0.16
Six months postop. 12.9 ± 3.4 13.6 ± 2.8 0.26
Nine months postop. 13.1 ± 3.1 13.8 ± 3.0 0.45
Twelve months postop. 14.1 ± 5.4 14.8 ± 3.1 0.42
mmHg, millimeters of mercury; postop., postoperatively.
a Unpaired t-test for intraocular pressure.
Table 3 Surgical complications and adverse events of the
studied patients.
Parameters Group Pa
Phaco-subscleral
trabeculectomy
Phaco-deep
sclerectomy
Posterior lens capsule tear 1 (5%) 0 (0%) 0.36
Vitreous loss 0 (0%) 0 (0%)
Perforation of TDM 0 (0%) 3 (15%) 0.75
Shallow anterior chamber 2 (10%) 0 (0%) 0.64
Hyphema (P2 mm) 2 (10%) 0 (0%) 0.71
Hypotony (<5 mmHg) 3 (15%) 1 (5%) 0.35
IOP spikes (P30 mmHg) 0 (0%) 3 (15%) 0.65
Posterior synechiae 2 (10%) 1 (5%) 0.15
Fibrin formation 2 (10%) 1 (5%) 0.45
Delayed bleb leaks 3 (15%) 1 (5%) 0.71
IOL decentration 1 (5%) 1 (5%) 0.35
Choroidal detachment 1 (5%) 0 (0%) 0.45
Endophthalmitis 0 (0%) 0 (0%)
TDM, Trabeculodescmetic membrane.
a Results of the paired t-test.
Table 4 Changes in visual ﬁeld and best-corrected visual
acuity in the studied patients.
Parameters Group Pa
Phaco-subscleral
trabeculectomy
Phaco-deep
sclerectomy
Mean deviation (dB)
Baseline 17.50 ± 5.41 18.83 ± 5.61 0.64
6 months 16.43 ± 4.49 16.95 ± 6.07 0.41
12 months 15.92 ± 5.32 16.27 ± 6.12 0.86
Best-corrected visual acuity
Base line (%)
P0.5 5 (25%) 3 (15%)
0.1–0.4 12 (60%) 13 (65%)
<0.1 3 (15%) 4 (20%)
Mean ± SD
(log MAR)
0.597 ± 0.81 0.641 ± 0.28 0.68
12 months (%)
P1.0 14 (70%) 16 (80%)
0.5–0.9 4 (20%) 3 (15%)
0.1–0.4 2 (10%) 1 (5%)
<0.1 0 (0%) 0 (0%)
Mean ± SD
(log MAR)
0.036 ± 0.061 0.029 ± 0.063 0.36
Log MAR, Logarithm of the minimum angle of resolution; SD,
standard deviation.
a Results of the paired t-test.
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glaucoma medication between both groups (P= 0.85,
P= 0.75, P= 0.68, P= 0.75, P= 0.52, and P= 0.75,
P= 0.46, respectively, v2-test and unpaired t-test).
Table 2 shows that there was signiﬁcant reduction
(P< 0.01) in IOP at all visit through out the follow-up period
in both groups. On the other hand, there was no signiﬁcant dif-
ference in mean postoperative IOP between the two groups at
intervals of 1 week, 1 month, 3 months, 6 months, 9 months,
and 12 months visits (P= 0.12, P= 0.18, P= 0.16, P=
0.26, P= 0.45, and P= 0.42 respectively), although the IOP
was lower in the subscleral trabeculectomy group at every visit.
Table 3 list postoperative complications and adverse events
in both groups. During deep sclerectomy, microperforation of
trabeculodescemetic membrane was noted without iris pro-
lapse or shallowing of the anterior chamber in 3 eyes (15%).
There was less hypotony and choroidal detachment in the deep
sclerectomy group than in the subscleral trabeculectomy;
hypotony and choroidal detachment were found in none of
the eyes (0%) in the deep sclerectomy group and in 4 eyes
(20%) in the subscleral trabeculectomy group. While delayed
bleb leaks were found 3 eyes (15%) in subscleral trabeculec-
tomy. All bleb were ﬂat and localized.Postoperative IOP spike was found in 3 eyes (15%) in the
deep sclerectomy group and 0 eye (0%) in the subscleral tra-
beculectomy group. There were no cases of bleb infection or
endophthalmitis in both groups.
Table 4 shows that mean deviation ± SD in Humphrey vi-
sual ﬁeld analyzer testing results at baseline was 17.50 ±
5.041 dB in the subscleral trabeculectomy group, and
18.83 ± 5.61 dB in the deep sclerectomy group (P= 0.64).
Improvement of mean deviation was 16.43 ± 4.49 dB at
6 months and 15.92 ± 5.35 dB at 12 months in the subscleral
trabeculectomy group, and 16.95 ± 6.07 dB at 6 months and
16.27 ± 6.12 dB at 12 months in the deep sclerectomy group
(P= 0.41 at 6 months; P= 0.86 at 12 months). At 12 months,
themean visual ﬁeld in the subscleral trabeculectomy group was
better than that in the deep sclerectomy group, but this
improvement was not statistically signiﬁcant.
In both groups, all eyes showed an increase of more than
0.2 in logarithm of the minimum angle of resolution best-cor-
rected visual acuity at 12 months compared with the preoper-
ative level. At 12 months, the mean best-corrected visual acuity
in the deep sclerectomy group was better than that in the sub-
scleral trabeculectomy group, but this improvement was not
statistically signiﬁcant.
Table 5 revealed the bleb outcomes in both groups. In sub-
scleral trabeculectomy group, a type I ﬁltering bleb was present
in 15 eyes, a type II ﬁltering bleb was present in 3 eyes, and a
type III bleb was present in 2 eyes. But in deep sclerectomy
group, a type I ﬁltering bleb was present in 16 eyes, a type II ﬁl-
tering bleb was present in 3 eyes, and a type III bleb in 1 eye. No
signiﬁcant difference in clinical bleb outcome between the two
groups. The favourable bleb appearance in group 1: 8 diffuse,
4 ﬂat, and 3 cystic. But, in group 2: 12 diffuse and 4 ﬂat.
Table 5 Bleb outcomes in the studied patients.
Parameters Group Pa
Phaco-subscleral
trabeculectomy
Phaco-deep
sclerectomy
No. of eyes 20 20
Bleb 1 15 (75%) 16 (80%) 0.31
Bleb 2 3 (15%) 3 (15%) 0.61
Bleb 3 2 (10%) 1 (5%) 0.43
Bleb 1, Favourable bleb; Bleb 2, intermediate bleb with scar slight;
Bleb 3, unfavourable bleb with progressive scarring.
a Results of v2-test.
Table 6 Surgical outcomes at 12 months in the studied
patients.
Parameters Group Pa
Phaco-subscleral
trabeculectomy
Phaco-deep
sclerectomy
No. of eyes 20 20
Overall success 18 (90%) 19 (95%) 0.35
Complete success 15 (75%) 16 (80%) 0.66
Qualiﬁed success 3 (15%) 3 (15%) 1.00
Failure 2 (15%) 1 (10%) 0.36
No. of anti-glaucoma
medications
0.1 ± 0.2 0.2 ± 0.4 0.41
a Results of v2-test.
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both groups. Eighteen eyes (90%) in the subscleral trabeculec-
tomy group and 19 eyes (95%) in the deep sclerectomy group
were considered to be successes, whereas 15 eyes (75%) in the
subscleral trabeculectomy group and 16 eyes (80%) in the deep
sclerectomy group were considered to be complete successes
(P= 0.7). Failure was recorded in 2 eyes (10%) in the subscle-
ral trabeculectomy group, and 1 eye (5%) in the deep sclerec-
tomy group (P= 0.4).
The mean number of anti-glaucoma medication decreased
from a preoperative level of 2.1 ± 0.8 to a postoperative level
of 0.1 ± 0.2 in the subscleral trabeculectomy group, and from
a preoperative level of 2.2 ± 0.6 to a postoperative level of
0.2 ± 0.4 in the deep sclerectomy group.
Complete success, IOP between 6 and 20 mmHg and IOP
reduction >30% without additional medical or surgical treat-
ment. Qualiﬁed success, IOP between 6 and 20 mmHg with
medical treatment or IOP reduction <30%; failure, new glau-
coma surgery required.
4. Discussion
A combined technique of cataract extraction and iridencleisis
was ﬁrst described by Birge (1952). Since then, the optimal sur-
gical approach for cataract patients with coexisting glaucoma
has been one of the most discussed topics among ophthalmic
surgeons.
Cataract surgery in patients with open-angle glaucoma re-
quires careful monitoring of postoperative pressure spikes;
combined procedures can reduce the frequency and magnitude
of this complications. Many authors have outlined the indica-tions for a combined procedure, but no simple technique with-
out the use of antimetabolites and with a low complications
rate has been presented (McCartney et al., 1988).
The IOP lowering potency of combined phacoemulsiﬁca-
tion, IOL implantation and trabeculectomy in patients with
open-angle glaucoma and cataract is well known. Thus, the
procedure is currently considered by most ophthalmic sur-
geons to be the standard technique for the treatment of uncon-
trolled glaucoma and cataract. Despite reﬁnements in the
phacoemulsiﬁcation trabeculectomy technique, some authors
have reported poor bleb formation and IOP control inferior
to that achieved after two-stage surgery or ﬁltration surgery
performed alone (Lu¨ke et al., 2007).
Recently, variants of non-penetrating surgery, such as deep
sclerectomy with or without an intrascleral implant has been
combined with phacoemulsiﬁcation and IOL implantations
(Funnell et al., 2005).
In the current study, we compare the surgical outcomes of
phaco-subscleral trabeculectomy and phaco-deep sclerectomy
with intraoperative mitomycin C (0.4 mg/ml) in eyes with pri-
mary open-angle glaucoma.
The mean IOP at the end of follow-up period in subscleral
trabeculectomy (14.1 ± 5.4 mmHg) was comparable to that
Kobayashi and Kobayashi (2007). While in deep sclerectomy
(14.8 ± 3.1 mmHg) was comparable to that reported by Fun-
nell et al. (2005).
At the end of the follow-up period, the mean IOP was re-
duced by 60.4% (14.2 mmHg versus 23.5 mmHg) for subscle-
ral trabeculectomy, and reduced by 61.4% (14.8 mmHg
versus 24.1 mmHg) for deep sclerectomy, thus showing less
intraocular pressure reduction of the mean IOP in subscleral
trabeculectomy (Lochhead et al., 2003). But there was no sig-
niﬁcant difference between the two groups.
IOP outcomes of subscleral trabeculectomy and deep scle-
rectomy with MMC augmentation were found to be similar
in this study. This similarity in outcomes has been previously
reported (Funnell et al., 2005), but has not been reported using
MMC (Gianoli et al., 1999).
Age, gender, and pretreatment medications were evaluated
as potential confounding variables at the end of study, and
were not found to be signiﬁcantly associated with any
confounder.
Considering the postoperative complications and adverse
events; shallow anterior chamber, hypotony, delayed bleb
leaks were observed in subscleral trabeculectomy group. This
coincide with Funnell et al. (2005). While microperforation
of trabeculodescemetic membrane and postoperative IOP
spikes were observed in deep sclerectomy group. But there
was no signiﬁcant difference between the two groups.
Mitomycin C augmentation is associated with thin walled
blebs and a high incidence of delayed bleb leaks. In this study,
the rates of MMC related complications are low. There was no
cases of bleb infection or endophthalmitis. This consistent with
Funnell et al. (2005).
Hypotony occurred in three patients who underwent selec-
tive argon Laser suturelysis after subscleral trabeculectomy,
and in one patient who underwent Laser goniopuncture after
deep sclerectomy. The frequency of delayed bleb leaks was
higher (15%) with subscleral trabeculectomy group than in
deep sclerectomy group (5%).
Gianoli et al. (1999) reported a lower incidence of postop-
erative inﬂammation and other immediate complications like
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over subscleral trabeculectomy. In this study, there were a
low incidence of postoperative complication in both groups,
but the possible beneﬁts of deep sclerectomy were offset by a
high incidence of intraoperative microperforation of trabecu-
lodescemetic membrane (15%).
Fibrinous anterior chamber inﬂammation and/or hypha-
ema were common in subscleral trabeculectomy group. Hy-
phema was trivial and resolved quickly. The signiﬁcance of
postoperative hyphema to the ﬁnal outcome of eyes that have
undergone antiglaucomatous surgery is a subject of contro-
versy. In the current study, no signiﬁcant difference with refer-
ence to success criteria was observed between eyes that
postoperatively showed a hyphaema and those that presented
without bleeding. These results coincide with Lu¨ke et al.
(2007), and conﬁrms the need to carefully monitor the compli-
cations in the immediate postoperative period.
At last follow-up, mean deviation of subscleral trabeculec-
tomy was 15.92 ± 5.32 dB, and of deep sclerectomy was
16.27 ± 6.12 dB. This difference between both groups was
not signiﬁcant (P= 0.86). In addition, improvement of mean
deviation in Humphrey visual ﬁeld analyzer testing was ob-
served in both groups.
The preoperative range of visual acuity in subscleral trabec-
ulectomy was 0.60 ± 0.81 and in deep sclerectomy was
0.64 ± 0.28. At last follow-up, the preoperative range of visual
acuity improved in subscleral trabeculectomy to 0.04 ± 0.06,
and in deep sclerectomy to 0.03 ± 0.06 at 12 months. No dif-
ference were observed in the improvement of visual acuity be-
tween the two groups (P= 0.36). This coincide with Funnell
et al. (2005). Failure of visual acuity improvement after sur-
gery included advanced glaucomatous optic neuropathy, mac-
ular oedema, and myopic shift (Chan et al., 2006).
Considering the postoperative bleb outcome, the current
study found that favourable blebs were 75% in subscleral tra-
beculectomy and 80% in deep sclerectomy, with no statistically
signiﬁcant difference between both groups. But, unfavourable
blebs were more in subscleral trabeculectomy with no statisti-
cally signiﬁcant. Postoperative blebs were ﬂat and localized.
The mean number of the preoperative anti-glaucoma med-
ications was 2.1 in subscleral trabeculectomy, and 2.2 in deep
sclerectomy to control. At the last follow-up, average number
of medications was 0.1 in subscleral trabeculectomy, and 0.2 in
deep sclerectomy at 12 months. The difference between two
groups was not signiﬁcant (P= 0.41). When IOP is well con-
trolled by small number of medications, some surgeons prefer
to perform cataract surgery alone for the patients coexisting
cataract and glaucoma. However, previous study reported that
the subscleral trabeculectomy provided good visual acuity with
minimal complications and signiﬁcantly IOP reduction
(Mamalis et al., 1996).
In the current study, the overall success rates of achieving
IOP <21 mmHg at postoperative 12 months were 90% in
the subscleral trabeculectomy group and 95% in the deep scle-
rectomy group, with no statistically signiﬁcant difference be-
tween both groups. Gianoli et al. (1999) reported that
combined surgery using the same target pressure criteria
showed qualiﬁed success rate at 12 months of 72% for subscle-
ral trabeculectomy and 88% for deep sclerectomy.
In the current study, during phacoemulsiﬁcation procedure,
a bottle height of approximately 100 cm was used rather than
75 cm bottle height frequently used by surgeons in glaucomapatients having surgery by conventional phacoemulsiﬁcation
techniques. The increase in bottle height was necessary to main-
tain a safe anterior chamber because of the greater resistance to
ﬂuid ﬂow through the irrigation chopper and deliberate allow-
ance of some ﬂuid leakage through the phacoemulsiﬁcation
wound for extra-protection against wound burn. Furthermore,
the mean duration the operated eye was connected to the bottle
was about 5 min. The effect of this on the optic nerve, specially
in those with advanced disease is uncertain (Tham et al., 2006).
The anterior chamber remained reasonably stable with this
technique. Thus, the procedure of bimanual phacoemulsiﬁca-
tion appeared to be safe and effective in eyes with coexisting
cataract and glaucoma. Advantages include avoiding US trau-
ma to the glaucoma site and that the phacoemulsiﬁcation cor-
neal wound size is kept to a minimum.
Jampel et al. (2002) have recently performed an evidence
based literature review of the effects of techniques on IOP after
combined cataract and glaucoma surgery. Their conclusion
based on the literature review was that the strongest evidence
of efﬁcacy exists for using (1) MMC, (2) separating the inci-
sions for cataract and glaucoma surgery, and (3) removing
the nucleus by phacoemulsiﬁcation.5. Conclusion
Combined phaco-subscleral trabeculectomy with MMC re-
sulted in excellent IOP control, substantial visual recovery, a
decrease in the number of glaucoma medications and, for com-
plications with no signiﬁcant difference in comparison to phac-
o-deep trabeculectomy with MMC in patients with primary
open-angle glaucoma.References
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